Published in Hippocampus on October 01, 1993
Integrating memories in the human brain: hippocampal-midbrain encoding of overlapping events. Neuron (2008) 3.25
Memory consolidation and the medial temporal lobe: a simple network model. Proc Natl Acad Sci U S A (1994) 3.06
The temporal context model in spatial navigation and relational learning: toward a common explanation of medial temporal lobe function across domains. Psychol Rev (2005) 2.60
Basal ganglia and dopamine contributions to probabilistic category learning. Neurosci Biobehav Rev (2007) 1.70
A pallidus-habenula-dopamine pathway signals inferred stimulus values. J Neurophysiol (2010) 1.60
L-dopa impairs learning, but spares generalization, in Parkinson's disease. Neuropsychologia (2005) 1.54
Generalization through the recurrent interaction of episodic memories: a model of the hippocampal system. Psychol Rev (2012) 1.35
Model-based choices involve prospective neural activity. Nat Neurosci (2015) 1.15
Generalization of value in reinforcement learning by humans. Eur J Neurosci (2012) 1.07
Aversive learning modulates cortical representations of object categories. Cereb Cortex (2013) 0.99
On the nature of CS and US representations in Pavlovian learning. Learn Behav (2012) 0.98
Action-effect bindings and ideomotor learning in intention- and stimulus-based actions. Front Psychol (2012) 0.97
A model of amygdala-hippocampal-prefrontal interaction in fear conditioning and extinction in animals. Brain Cogn (2012) 0.96
Conceptual similarity promotes generalization of higher order fear learning. Learn Mem (2011) 0.96
Associative learning over trials activates the hippocampus in healthy elderly but not mild cognitive impairment. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2008) 0.95
Differential outcome effects in pavlovian biconditional and ambiguous occasion setting tasks. J Exp Psychol Anim Behav Process (2010) 0.92
The CRISP theory of hippocampal function in episodic memory. Front Neural Circuits (2013) 0.91
Neural Differentiation Tracks Improved Recall of Competing Memories Following Interleaved Study and Retrieval Practice. Cereb Cortex (2014) 0.90
Transverse patterning and human amnesia. J Cogn Neurosci (2006) 0.90
The role of the cerebellar interpositus nucleus in short and long term memory for trace eyeblink conditioning. Behav Neurosci (2009) 0.89
Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: implications for translational research. Neurobiol Aging (2009) 0.89
Memory encoding and dopamine in the aging brain: a psychopharmacological neuroimaging study. Cereb Cortex (2009) 0.88
Learning to smell danger: acquired associative representation of threat in the olfactory cortex. Front Behav Neurosci (2014) 0.87
Hippocampal lesion effects on occasion setting by contextual and discrete stimuli. Neurobiol Learn Mem (2010) 0.86
What representations and computations underpin the contribution of the hippocampus to generalization and inference? Front Hum Neurosci (2012) 0.85
Computational models of the hippocampal region: implications for prediction of risk for Alzheimer's disease in non-demented elderly. Curr Alzheimer Res (2006) 0.83
A neural model of hippocampal-striatal interactions in associative learning and transfer generalization in various neurological and psychiatric patients. Brain Cogn (2010) 0.83
Experience-dependent hippocampal pattern differentiation prevents interference during subsequent learning. Nat Commun (2016) 0.83
Surprised at all the entropy: hippocampal, caudate and midbrain contributions to learning from prediction errors. PLoS One (2012) 0.81
Learning and generalization from reward and punishment in opioid addiction. Behav Brain Res (2016) 0.79
Cognitive performance is highly sensitive to prior experience in mice with a learning and memory deficit: failure leads to more failure. Learn Mem (2005) 0.78
Contributions of the hippocampus to feedback learning. Cogn Affect Behav Neurosci (2015) 0.78
Why trace and delay conditioning are sometimes (but not always) hippocampal dependent: a computational model. Brain Res (2012) 0.78
Hippocampal lesions can enhance discrimination learning despite normal sensitivity to interference from incidental information. Hippocampus (2011) 0.77
Loss of hippocampal function impairs pattern separation on a mouse touch-screen operant paradigm. Neurobiol Learn Mem (2015) 0.77
The mystery of structure and function of sensory processing areas of the neocortex: a resolution. J Comput Neurosci (2002) 0.76
Conditional discrimination and reversal in amnesia subsequent to hypoxic brain injury or anterior communicating artery aneurysm rupture. Neuropsychologia (2006) 0.76
Amnesic patients show superior generalization in category learning. Neuropsychology (2016) 0.75
Human electrophysiological correlates of learned irrelevance: effects of the muscarinic M1 antagonist biperiden. Int J Neuropsychopharmacol (2011) 0.75
The computational nature of memory modification. Elife (2017) 0.75
Deficits in hippocampal-dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosis. Hippocampus (2015) 0.75
Integration of exteroceptive and interoceptive information within the hippocampus: a computational study. Front Syst Neurosci (2015) 0.75
Hippocampal mismatch signals are modulated by the strength of neural predictions and their similarity to outcomes. J Neurosci (2016) 0.75
Suppression of Ventral Hippocampal Output Impairs Integrated Orbitofrontal Encoding of Task Structure. Neuron (2017) 0.75
Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci U S A (1994) 6.74
Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science (1977) 3.11
Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clin Pharmacol Ther (1987) 2.92
Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem (1986) 2.88
Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep (1978) 2.42
Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides. N Engl J Med (1989) 2.17
Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest (1980) 2.03
Influence of Dead Bacteria on Microscopic Counts of Pasteurized Milk. Am J Public Health Nations Health (1937) 2.02
The anthracycline antineoplastic drugs. N Engl J Med (1981) 2.02
Cortico-striatal contributions to feedback-based learning: converging data from neuroimaging and neuropsychology. Brain (2004) 2.00
Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc Natl Acad Sci U S A (1988) 1.86
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res (1989) 1.86
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res (1996) 1.82
Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci U S A (1998) 1.74
Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun (2000) 1.73
Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc Natl Acad Sci U S A (1986) 1.71
Basal ganglia and dopamine contributions to probabilistic category learning. Neurosci Biobehav Rev (2007) 1.70
Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer. Am J Med (1995) 1.60
Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res (1990) 1.57
Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Res (1979) 1.55
Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders. J Clin Pharmacol (1988) 1.51
Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Cancer Res (1983) 1.47
Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest (1981) 1.46
Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol (1989) 1.45
Suramin-induced skin reactions. Arch Dermatol (1992) 1.45
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res (1981) 1.45
Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci U S A (1994) 1.44
Mode of action of 5-fluorocytosine. Biochem Pharmacol (1978) 1.40
Role of the basal ganglia in category learning: how do patients with Parkinson's disease learn? Behav Neurosci (2004) 1.38
The clinical pharmacology of antineoplastic agents (first of two parts). N Engl J Med (1975) 1.35
Phase I study of phenylacetate administered twice daily to patients with cancer. Cancer (1995) 1.33
Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res (1988) 1.32
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun (1997) 1.31
Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. Clin Pharmacol Ther (1989) 1.27
Competitive protein binding assay for methotrexate. Proc Natl Acad Sci U S A (1975) 1.21
Nonlinear pharmacokinetic models for 5-fluorouracil in man: intravenous and intraperitoneal routes. Clin Pharmacol Ther (1980) 1.21
Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc Natl Acad Sci U S A (1987) 1.21
Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Res (1980) 1.20
Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res (1988) 1.20
Characterization of the cycle of iron-mediated electron transfer from Adriamycin to molecular oxygen. J Biol Chem (1985) 1.18
High-dose cisplatin in hypertonic saline in refractory ovarian cancer. J Clin Oncol (1985) 1.18
Adriamycin: amelioration of toxicity by alpha-tocopherol. Cancer Treat Rep (1976) 1.16
Human ultrastructure. IV. Collecting duct of healthy individuals. Lab Invest (1966) 1.14
Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance. Cancer Res (1989) 1.11
Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection. J Clin Pharmacol (1986) 1.09
Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate. J Clin Invest (1993) 1.08
Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res (1982) 1.08
Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells. Cancer Res (1989) 1.06
Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion. J Clin Invest (1975) 1.06
Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action. Biochemistry (1987) 1.06
The clinical pharmacology of antineoplastic agents (second of two parts). N Engl J Med (1975) 1.05
Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. Surg Gynecol Obstet (1982) 1.03
Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell lines. Biochem Pharmacol (1986) 1.02
Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells. Mol Pharmacol (1995) 1.02
Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res (1995) 1.02
Determination of optimal freezing parameters of human prostate cancer in a nude mouse model. Prostate (1999) 1.02
Evaluation of tamoxifen dose in advanced breast cancer: a progress report. Cancer Treat Rep (1976) 1.01
Effect of suramin on human prostate cancer cells in vitro. J Urol (1991) 1.00
Suramin: prototype of a new generation of antitumor compounds. Cancer Cells (1990) 1.00
Clinical pharmacology of anticancer drugs. Semin Oncol (1977) 0.99
A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer. Tumori (1998) 0.99
Late-training amnesic deficits in probabilistic category learning: a neurocomputational analysis. Learn Mem (1999) 0.98
Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer. J Natl Cancer Inst (1994) 0.98
A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer. Clin Cancer Res (1999) 0.98
Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3. Proc Natl Acad Sci U S A (1992) 0.98
Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics. AJR Am J Roentgenol (1979) 0.97
Psychobiological models of hippocampal function in learning and memory. Annu Rev Psychol (1997) 0.97
Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography. Ann Intern Med (1981) 0.97
Comparison of the effectiveness of (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles. Cancer Res (1985) 0.97
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane. Br J Cancer (1993) 0.97
Inhibition of human ovarian cancer colony formation by adriamycin and its major metabolites. Cancer Res (1980) 0.97
Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers. Adv Exp Med Biol (1997) 0.96
Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res (1994) 0.96
Quantitative study of guide-field effects on Hall reconnection in a laboratory plasma. Phys Rev Lett (2012) 0.96
Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques. Biochem Pharmacol (1978) 0.95
High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early results. Cancer Chemother Pharmacol (1978) 0.95
Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables. Cancer (1995) 0.95
Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma. J Clin Oncol (1986) 0.95
Prospective randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer. Semin Oncol (1985) 0.94
Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation. Int J Cancer (1993) 0.94
Serial determinations of glutathione levels and glutathione-related enzyme activities in human tumor cells in vitro. Biochem Pharmacol (1986) 0.94
Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex. Biochemistry (1982) 0.93
Experimental animal models of adriamycin cardiotoxicity. Cancer Treat Rep (1979) 0.93
Probabilistic categorization: how do normal participants and amnesic patients do it? Neurosci Biobehav Rev (2007) 0.93
Circulating glycosaminoglycan anticoagulants associated with suramin treatment. Blood (1988) 0.92
Patient experiences with a child-resistant prescription container. Am J Hosp Pharm (1977) 0.92
P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J Clin Invest (1992) 0.92
Hydroxyl radical production and DNA damage induced by anthracycline-iron complex. FEBS Lett (1984) 0.92
Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography. Am J Cardiol (1986) 0.92
A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: toxicity and response. Cancer Chemother Pharmacol (1996) 0.91
A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240). Cancer Res (1983) 0.91
A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation. Int J Radiat Oncol Biol Phys (1984) 0.90
Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. J Biol Chem (1988) 0.90
Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells. Endocrinology (1996) 0.90
New developments on the mechanisms of action of antineoplastic drugs. Life Sci (1979) 0.89
Monoclonal antibodies to glutathione S-transferase pi-immunohistochemical analysis of human tissues and cancers. Int J Cancer (1991) 0.89
Assay of 5-fluorodeoxyuridine 5'-monophosphate deoxyuridine 5'-monophosphate pools following 5-fluorouracil. Cancer Res (1974) 0.89
Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells. Biochem Pharmacol (1987) 0.89
Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: implications for translational research. Neurobiol Aging (2009) 0.89